ImmunityBio Statistics
NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.02-0.55 (-8.37%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ImmunityBio by the numbers
ImmunityBio has a market capitalization of $6.40 billion based on 1.06B shares outstanding. With trailing EPS of $-1.06, ImmunityBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.5% below its 50-day average and 24.5% below its 200-day average.
Average daily trading volume is 12.97M shares, or about $78.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IBRX valuation vs. peer median
| Metric | IBRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.40B | $6.46B | -1% |
| Avg. volume | 12.97M | 1.82M | +614% |
Peer median across 8 companies: KOD, IMVT, SRRK, TWST, CGON, ADPT, PCVX, CRSP.
Valuation
- Market cap
- $6.40B
- Price / sales (latest FY)
- 56.53
- EPS (TTM)
- $-1.06
- Shares outstanding
- 1.06B
Price and trading
- Previous close
- 6.57
- Open
- 6.41
- Day range
- 6.00 – 6.53
- 52-week range
- 1.95 – 12.43
- 52-week change
- +189.42%
- Beta
- —
- Volume
- 10.57M
- Average volume
- 12.97M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 6.40B
- Forward Pe
- -20.07
- Eps
- -1.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.43
- Week52 Low
- 1.95
- Avg Volume
- 12.97M
- Shares Outstanding
- 1.06B
- Ma50
- 8.42
- Ma200
- 7.98
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -51.57%
- Pct From52w Low
- 208.72%